Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business Operations (Details)

v3.20.1
Organization and Description of Business Operations (Details) - shares
1 Months Ended
Apr. 12, 2016
Apr. 22, 2016
Jan. 31, 2016
Dec. 31, 2019
Organization and Description of Business Operations [Textual]        
Common stock shares issued   5,800,000   22,000,000
Warrants issued   1,000,000    
Intellectual property, description The Company and HP entered into the first amendment to the agreement, which reduced the purchase price of the technology to $175,000, of which $75,000 was payable upon completion of the technology transfer and $100,000 was payable upon the first anniversary of the agreement's effective date. On May 1, 2017, the Company and HP entered into the second amendment to the agreement which increased the purchase price for the technology to $375,000 and extended the closing date to January 31, 2020. Of such $375,000, $75,000 is payable upon completion of the technology transfer, $100,000 is payable upon the first anniversary of the agreement's effective date, $100,000 is payable upon the second anniversary of the agreement's effective date and $100,000 is payable upon the third anniversary of the agreement's effective date. On March 10, 2019, the Company and HP entered into the third amendment to the agreement, which extended the closing date to January 31, 2021, enumerated certain intellectual property owned by HP that is not subject to the exclusive license granted to the Company and revised the schedule of fees payable by the Company to HP, such that $100,000 is payable upon the first anniversary of the agreement's effective date, $100,000 is payable upon the second anniversary of the agreement's effective date and $100,000 is payable before April 20, 2019. As of December 31, 2019 and the date of this report, the remaining $100,000 owed to HP for the research license has not been paid. The parties have subsequently agreed that such payment is not due until April 29, 2020. The agreement grants the Company an option to purchase the related assignable patents at a purchase price of $1.4 million.   Under the terms of the agreement, the license is to be used for research purposes only, has a purchase price of $200,000 for the technology and has a two-year closing date.